Related Experiment Video
Updated: Dec 31, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
The roles of m6A RNA modifiers in human cancer
Yanwen Liang1, Guankai Zhan2, Kao-Jung Chang3,4
1Department of Life Sciences and Institute of Genomic Sciences, National Yang-Ming University, Taipei, Taiwan, ROC.
Abstract:
Like DNA and proteins, RNA is subject to numerous (over 160) covalent modifications which play critical roles to regulate RNA metabolism. Among these modifications, N-methyladenosine (mA) is the most prevalent RNA methylation on mRNA which occurs on around 25% of transcripts. The recent studies demonstrated that mA participates in many aspects of RNA processing, including splicing, nuclear exporting, translation, stabilization, etc. Therefore, it revealed a new layer of regulatory mechanism for gene expression and has been termed "RNA Epigenetics" or "Epitranscriptomics". RNA mA is regulated and exerts its functions by three groups of "mA RNA modifiers" including mA methyltransferases (writers), mA demethylases (erasers), and mA binding proteins (readers). In this review, we would summarize and discuss the current understandings of the roles of the conventional mA RNA modifiers in human cancers.
Insights
N-methyladenosine (mA), a key RNA modification, regulates gene expression and RNA processing. This review explores how mA RNA modifiers impact human cancers, revealing new therapeutic targets.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- RNA modifications, including N-methyladenosine (mA), are crucial for regulating gene expression and RNA metabolism.
- mA is the most abundant mRNA methylation, impacting ~25% of transcripts and influencing processes like splicing, translation, and stability.
- This regulatory layer is termed "RNA Epigenetics" or "Epitranscriptomics".
Purpose of the Study:
- To review and discuss the current understanding of mA RNA modifiers in human cancers.
- To highlight the roles of mA methyltransferases (writers), mA demethylases (erasers), and mA binding proteins (readers) in cancer development and progression.
Main Methods:
- Literature review of recent studies on mA RNA modifiers and their functions.
- Analysis of the involvement of mA modifiers in various aspects of RNA processing relevant to cancer.
Main Results:
- mA modifications are implicated in diverse cellular processes, including splicing, nuclear export, translation, and RNA stability.
- Dysregulation of mA RNA modifiers is increasingly recognized as a significant factor in human cancers.
- mA modifiers act as "writers," "erasers," and "readers" to control mA levels and functions.
Conclusions:
- mA RNA modifiers represent a critical regulatory network in gene expression with profound implications for cancer.
- Understanding these "epitranscriptomic" mechanisms offers potential for novel cancer diagnostics and therapeutics.
Related Concept Videos
MicroRNAs
MicroRNAs
RNA Stability
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Nuclear Export of mRNA

